Named catch-up gap: management identifies where the company visibly lags peers or its own potential, and is already clos
The model's full reasoning — Q1 2017 call → NOWe need to determine if management identifies a specific, named dimension on which the company currently underperforms relative to peers, norms, or its own potential, and describes work already underway to close that gap, with management treating it as a meaningful source of improvement not dependent on market conditions. Let's scan the transcript for such a diagnosis. Management discusses various issues: U.S. consumption softness, Canada go-to-market delays, Europe currency headwinds, Rest of World investments. They mention cost savings, integration program, etc. But is there a specific named gap? For example, they mention "we lost distribution of certain less profitable products" but that's not a gap. They mention "we restricted ourselves from promoting Oscar Mayer and meats for quite some time" and that restriction has been lifted. That could be a gap: they had a self-imposed restriction on new products in meat business, and now they are lifting it. But is that a "named dimension on which the company currently underperforms"? They say "we will start to increase both innovation and renovation activities to improve our performance in challenged categories, particularly at the back half of the year." That is more of a plan. Also, they mention "we are on track with our cost savings initiatives" and "cumulative savings from our Integration Program are approximately $1.3 billion" and they expect to reach $1.7 billion. That is a cost savings target, but is that a gap? They don't say they are underperforming on cost savings; they say they are on track. Look for a specific gap: Perhaps the U.S. performance? They say "there is no questioning the slow start to 2017 with greater than expected declines" but they attribute it to calendar changes and distribution losses. They don't say they are underperforming relative to peers on a specific metric. They mention "we had solid price realization" but that's not a gap. Another possibility: They mention "we have a much stronger retail calendar in the U.S. for the balance of the year" and "we expect and have already being seeing our restoration of normal go-to-market activity in Canada" - that is about external conditions improving.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| MEG | Montrose Environmental Group, Inc. | Q3 2023 | 2023-11-08 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| CMG | Chipotle Mexican Grill, Inc. | Q3 2023 | 2023-10-27 | B+ |
| SWK | Stanley Black & Decker, Inc. | Q1 2023 | 2023-05-04 | D |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| ADNT | Adient plc | Q1 2018 | 2018-01-29 | D |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| STKL | SunOpta Inc. | Q2 2017 | 2017-08-09 | C+ |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| ABM | ABM Industries Incorporated | Q2 2017 | 2017-06-08 | B |
| PPG | PPG Industries, Inc. | Q1 2017 | 2017-04-20 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| SXT | Sensient Technologies Corporation | Q4 2016 | 2017-02-10 | A |
| BC | Brunswick Corporation | Q3 2016 | 2016-10-28 | B+ |
| SON | Sonoco Products Company | Q4 2015 | 2016-02-11 | B |
HOLX · Q4 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly diagnosing Cynosure’s commercial organization as the specific underperforming dimension (salesforce turnover, recruiting, and productivity lagging behind the company’s international business and its own best operations). They then describe concrete, already-executing actions—stopping voluntary turnover, rehiring high performers, instituting 90-day reviews, new compensation, and building “Cynosure 2.0”—as the mechanism to close the gap.
STKL · Q2 2017 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management identifying a specific named gap in the bars segment, where operational issues at a particular facility are causing inefficient production and gross margin losses. They describe a rapid recovery team already executing systematic identification and correction of these issues, treating the gap as closable through their own operational efforts rather than external market improvements — this aligns with the criteria for a meaningful source of improvement.
ADNT · Q1 2018 → YESThe question is: Does management identify a specific, named dimension on which the company currently underperforms — relative to industry peers, industry norms, or the company's own demonstrated poten...YES The transcript shows management explicitly naming the Seat Structures and Mechanisms (SS&M) business as the specific underperforming dimension. They state it is “destroyed shareholder value” when run as currently organized, and that it is “impacting our financial results” with “significant impact.